Setmelanotide — Discount Pricing
Setmelanotide is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Setmelanotide Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $78.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Setmelanotide
Setmelanotide is a prescription medication. Ask your doctor if Setmelanotide is right for you.
How to Check Setmelanotide Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Setmelanotide at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Weight Management
About Setmelanotide
Setmelanotide (brand name Imcivree) represents a significant advancement for individuals living with specific genetic forms of obesity. This highly specialized medication targets underlying causes of severe hunger. Understanding this innovative treatment and its potential costs is crucial. At TheDrugClub, we are dedicated to helping our members navigate complex prescription pricing and discover potential savings.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Setmelanotide is approved for (FDA label)
IMCIVREE is indicated to reduce excess body weight and maintain weight reduction long term in adults and pediatric patients aged [ see Dosage and Administration (2.1) ]: 4 years and older with acquired hypothalamic obesity (HO) 2 years and older with syndromic or monogenic obesity due to: o Bardet-Biedl syndrome (BBS) o Pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency confirmed by genetic testing demonstrating variants in POMC, PCSK1, or LEPR genes that are interpreted as pathogenic, likely pathogenic, or of uncertain significance (VUS).
Source: Read the full FDA label on DailyMed. Label effective date: April 1, 2026.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.